← Back to Intel
Insider ActivityOKYO
Shah Keeren Rameshchandra, Chief Financial Officer at OKYO Pharma Ltd, traded $74K of OKYO
Updated Jun 19, 2026
Shah Keeren Rameshchandra
Chief Financial Officer
OKYO Pharma Ltd ·
$OKYO
Transaction Details
| Insider | Shah Keeren Rameshchandra |
|---|---|
| Title | Chief Financial Officer |
| Company | OKYO Pharma Ltd |
| Ticker | OKYO |
| Transaction Type | Grant |
| Transaction Date | 2026-06-08 |
| Shares Traded | 40,000 |
| Price Per Share | $1.85 |
| Total Value | $74K |
| Filed Date | 2026-06-10 |
| Accession Number | 0001493152-26-028131 |
Ownership Context
| Shares Owned After Transaction | — |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001493152-26-028131
Other Insider Trades — OKYO
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| CERRONE GABRIELE M | Director, 10% Owner | traded | $516K | 2026-06-08 |
| Denoyer Bernard | Director | traded | $6K | 2026-06-08 |
| BRANCACCIO JOHN P | Director | traded | $12K | 2026-06-08 |
| Simon Willy Jules | Director | traded | $12K | 2026-06-08 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for OKYO — OKYO Pharma Ltd →
Track OKYO insider activity in real time on The Wire →
Get alerts when Shah Keeren Rameshchandra files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 19, 2026 at 07:03 UTC